Summary
AXIS-SHIELD, the Scots-Norwegian diagnostics company, yesterday cleared another hurdle in its plans to launch a test that could help prevent the onset of Alzheimer's disease.
The company, which has its headquarters in Dundee and Oslo, has won regulatory approval from the US Food & Drug Administration to sell its patented test for the measurement of vitamin B12 to American research scientists.See the full content of this document
Extract
Axis Sees Us Approval for Alzheimer's Treatment
Low levels of B12 are thought to be associated with neurological damage and dementia...
See the full content of this document
Sponsored links
